Margaret L. Dorsett, PA

Dr. Scalea is a board-certified surgeon specializing in kidney, pancreas, liver, and islet cell transplantation. Dr. Scalea's patient care philosophy is to treat his patients with a meticulous focus on excellence and compassionate care. His clinical area of expertise is in abdominal organ transplantation, with a special interest in kidney, pancreas, and islet cell transplantation. Dr. Scalea has achieved outstanding results in his simultaneous kidney and pancreas (SPK) transplant recipients. At MUSC Health, he is the Surgical Director of the Kidney Transplant Program and the Director of Hepatology, Nephrology, and Transplant ICCE Quality and Innovation.Dr. Scalea's research interests focus on improving outcomes and access to care for patients needing life-saving transplantation and researching strategies to achieve immune tolerance in allogeneic solid organ transplantation. He received international notoriety in 2019 for pioneering drones for organ transplants. As the inaugural Vice Chair of Surgery for Innovation, Dr. Scalea will expand his experience in clinical medicine, academic leadership, commercialization, and innovation to help translate innovative ideas from the laboratory to industry.Dr. Scalea received his medical degree and surgical training from the University of Maryland and completed his transplant fellowship at the University of Wisconsin and his post-doctoral fellowship at the Harvard Medical School, Transplantation Biology Research Center.When not in the clinic or laboratory, Dr. Scalea enjoys painting and performing music. His artworks are currently on display in Baltimore and Washington, D.C. Dr. Scalea is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Pancreas Transplant, and Kidney Transplant. Dr. Scalea is currently accepting new patients.

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Scleroderma, Heart Transplant, and Lung Transplant. Dr. Tedford is currently accepting new patients.

Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. Dr. Judge is currently accepting new patients.

Prabhakar Baliga, M.D. FACS is a transplant surgeon and chair of the MUSC Department of Surgery, where he leads a diverse range of programs and services spanning nine clinical divisions, in addition to the Department's research and education divisions. Dr. Baliga's philosophy is to treat his patients with a primary focus on excellence and compassionate care. His clinical focus is in abdominal organ transplant with a special interest in kidney, liver and pancreas transplantation. He treats patients who are experiencing kidney failure, particularly with polycystic kidney disease; liver failure, liver cancer and patients who have issues with their bile duct, a series of thin tubes that go from the liver to the small intestine. ,He has served many leadership positions that have positively impacted the growth and expertise of the MUSC Health transplant program, the only solid organ transplant center in South Carolina. Prior to assuming the role of Department Chair, Dr. Baliga was named MUSC's ICCE Leader for Transplant, Nephrology & Hepatology and served on the Board of Life Point, an organ procurement agency. He has also served on the board for the United Network for Organ Sharing and the board of directors for the South Carolina chapter of the National Kidney Foundation. He is on the leadership of the state-wide SC surgical quality collaborative that is focused on improving care of surgical patients across SC. He currently serves on the American College of Surgeons Board of Governors as the Surgical Specialty Society Governor from the Southern Surgical Association.Dr. Baliga was awarded his medical degree by Madras Medical College in India. He completed his surgical residency at Tulane University and his transplant fellowship at the University of Michigan. Dr. Baliga is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Kidney Transplant, and Pancreas Transplant. Dr. Baliga is currently accepting new patients.

Dr. Luca Paoletti received his BA in biology from the University of Virginia and his medical degree from St. George's University. He completed internship and residency in internal medicine at the University of Connecticut Medical Center, where he was selected to serve as chief resident. He completed sub-specialty training in pulmonary and critical care medicine at the Medical University of South Carolina, where he is currently an associate professor of medicine and is the Medical Director of the Adult ECMO program and the Medical Director of Pulmonary Rehabilitation. His teaching activities and patient care are focused in the area of pulmonary transplant medicine. Dr. Paoletti is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Bronchiolitis Obliterans, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Bone Marrow Aspiration. Dr. Paoletti is currently accepting new patients.

Dr. Ira Willner is an associate professor of medicine in the Division of Gastroenterology and Hepatology at the Medical University of South Carolina. He is also the director of the fellowship training program for gastroenterology and hepatology. Dr. Willner completed his medical degree (M.D.) at the SUNY Health Science Center in Syracuse, New York in 1990. He then completed a two-year fellowship in gastroenterology at the New York Medical College in Valhalla, New York in 1995, followed by a one-year fellowship in liver disease at the University of Tennessee in 1996. He is board certified in internal medicine and gastroenterology. Dr. Willner is a member of several professional organizations, including the American Association for the Study of Liver Disease, European Association for the Study of the Liver, American College of Physicians, American Medical Association, and the American College of Gastroenterology. Additionally, Dr. Willner was awarded the Department of Internal Medicine attending of the year in 2000. Dr. Willner's clinical interests include liver disease, treatment of portal hypertension, and viral hepatitis. Dr. Willner is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Enlarged Liver, Endoscopy, and Liver Transplant. Dr. Willner is currently accepting new patients.